Raymond James & Associates Natera, Inc. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Natera, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 57,840 shares of NTRA stock, worth $7.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,840
Previous 33,020 75.17%
Holding current value
$7.21 Million
Previous $3.58 Million 105.62%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$97.75 - $129.67 $2.43 Million - $3.22 Million
24,820 Added 75.17%
57,840 $7.35 Million
Q2 2024

Jul 19, 2024
BUY
$85.28 - $112.6 $312,039 - $412,003
3,659 Added 12.46%
33,020 $3.58 Million
Q1 2024

Apr 22, 2024
SELL
$59.21 - $92.9 $113,801 - $178,553
-1,922 Reduced 6.14%
29,361 $2.69 Million
Q4 2023

Jan 16, 2024
SELL
$37.55 - $62.64 $2,403 - $4,008
-64 Reduced 0.2%
31,283 $1.96 Million
Q3 2023

Oct 24, 2023
SELL
$43.4 - $62.52 $22,958 - $33,073
-529 Reduced 1.66%
31,347 $1.39 Million
Q2 2023

Jul 25, 2023
BUY
$47.08 - $55.16 $1.5 Million - $1.76 Million
31,876 New
31,876 $1.55 Million
Q4 2022

Feb 08, 2023
SELL
$34.17 - $47.91 $32,632 - $45,754
-955 Reduced 15.22%
5,320 $213,000
Q3 2022

Oct 25, 2022
BUY
$36.93 - $56.68 $231,735 - $355,667
6,275 New
6,275 $275,000
Q1 2022

May 11, 2022
SELL
$30.32 - $91.33 $129,375 - $389,705
-4,267 Closed
0 $0
Q4 2021

Feb 08, 2022
SELL
$86.26 - $119.0 $77,375 - $106,743
-897 Reduced 17.37%
4,267 $398,000
Q3 2021

Nov 02, 2021
SELL
$100.17 - $126.36 $34,758 - $43,846
-347 Reduced 6.3%
5,164 $575,000
Q2 2021

Aug 11, 2021
SELL
$86.05 - $119.72 $1.36 Million - $1.89 Million
-15,750 Reduced 74.08%
5,511 $626,000
Q1 2021

May 14, 2021
SELL
$91.47 - $124.36 $14,269 - $19,400
-156 Reduced 0.73%
21,261 $2.16 Million
Q4 2020

Feb 12, 2021
BUY
$66.66 - $111.74 $49,928 - $83,693
749 Added 3.62%
21,417 $2.13 Million
Q3 2020

Nov 04, 2020
BUY
$45.89 - $72.67 $551,964 - $874,074
12,028 Added 139.21%
20,668 $1.49 Million
Q2 2020

Jul 28, 2020
BUY
$26.36 - $49.86 $227,750 - $430,790
8,640 New
8,640 $431,000
Q1 2020

Apr 21, 2020
SELL
$17.27 - $40.17 $141,924 - $330,117
-8,218 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$32.1 - $40.4 $263,797 - $332,007
8,218 New
8,218 $277,000
Q3 2019

Nov 07, 2019
SELL
$25.38 - $34.89 $401,384 - $551,785
-15,815 Closed
0 $0
Q2 2019

Aug 06, 2019
BUY
$17.75 - $27.58 $280,716 - $436,177
15,815 New
15,815 $436,000

Others Institutions Holding NTRA

# of Institutions
512
Shares Held
120M
Call Options Held
412K
Put Options Held
270K
View Full List

About Natera, Inc.

NTRA Quotes by TradingView
  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $12.1B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email